Prevalence of chronic kidney disease risk factors among low birth weight adolescents

Dev Darshan K Khalsa1, Hind A Beydoun2, J Bryan Carmody3

  • 1Eastern Virginia Medical School, Norfolk, VA, USA.

Insights

Adolescents with low birth weight (LBW) have higher risks for elevated blood pressure and decreased kidney function. These findings highlight the importance of monitoring kidney health in LBW individuals during adolescence.

Area of Science:

  • Pediatrics
  • Nephrology
  • Public Health

Background:

  • Infants born with low birth weight (LBW) face increased risks for chronic kidney disease (CKD) in adulthood.
  • However, the presence of objective CKD risk factors in earlier life stages remains unclear.

Purpose of the Study:

  • To investigate the prevalence of CKD risk factors in adolescents with a history of LBW.
  • To determine if LBW is associated with elevated blood pressure and reduced kidney function in adolescents.

Main Methods:

  • Analysis of 5352 adolescents (aged 12-15 years) from the National Health and Nutrition Examination Survey (1999-2012).
  • Participants categorized into low birth weight (LBW; <2500 g), very low birth weight (VLBW; <1500 g), or normal birth weight groups.
  • CKD risk factors assessed included albuminuria, decreased estimated glomerular filtration rate (eGFR), and elevated systolic blood pressure (BP).

Main Results:

  • Albuminuria levels did not differ significantly across birth weight groups.
  • Adolescents in LBW/VLBW groups showed higher frequencies of elevated systolic BP and decreased eGFR compared to normal birth weight peers.
  • Multivariable analysis confirmed that LBW/VLBW adolescents had significantly greater odds for both elevated BP and decreased eGFR.

Conclusions:

  • Elevated systolic blood pressure and decreased eGFR are common in U.S. adolescents with a history of LBW/VLBW.
  • These findings underscore the need for early monitoring of kidney health in individuals born with low birth weight.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.0K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
909
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
595
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
295
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
548
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.3K